Stock Groups

U.S. administers 425.3 million doses of COVID-19 vaccines


© Reuters. FILE PHOTO A patient receives the COVID-19 vaccination at a Philadelphia clinic, Pennsylvania on May 18, 2021. REUTERS/Hannah Beier

(Reuters) – As of Wednesday morning, 425,272,828 COVID-19 vaccinations had been administered in America. The United States Centers for Disease Control and Prevention reported that 525,071,855 vaccines were distributed.

These figures represent an increase in vaccine dosages, which the CDC stated had reached arms as of Nov. 2. This is in addition to the 521.502,845 administered doses.

It stated that 222,268,786 had been given at least one dose and that 192,931,486 of them were complete vaccinated. This was as of 6:06 a.m. ET on Wednesday

Two-dose vaccinations are included in the CDC tally Moderna (NASDAQ:) and Pfizer/BioNTech,, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

Around 20.6 Million people have had a booster of one. Pfizer (NYSE:), Moderna or Johnson & Johnson’s COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.